Stock Market News To Give You An Edge

Proven Track Record of Most Accurate Analysis

Stock Market News
To Give You An Edge​

Proven Track Record
of Most Accurate Analysis

COMPLETELY INDEPENDENT AND OBJECTIVE

The Arora Report, Ltd. is a rare publisher that does not accept advertisements. This way The Arora Report can not be influenced. The Arora Report also does not accept payments from any company that is the subject of the posts. The Arora Report has forsaken millions of dollars in revenues to avoid conflicts of interest. Our sole job is to help you. Read more.

COMPLETELY INDEPENDENT AND OBJECTIVE

The Arora Report, Ltd. is a rare publisher that does not accept advertisements. This way The Arora Report can not be influenced. The Arora Report also does not accept payments from any company that is the subject of the posts. The Arora Report has forsaken millions of dollars in revenues to avoid conflicts of interest. Our sole job is to help you. Read more.

WEEKLY MARKET DIGEST: STRONG BUT INDECISIVE JOBS REPORT, STUNNING TORY VICTORY, POUND SURGES AND OIL SHORT SQUEEZE ABATES $GLD $SLV $USO $DIA $SPY $QQQ $TBF $TBT

  (The Weekly Digest reproduces the morning capsules made available every morning before the market open in the Real Time Feeds to the paying subscribers. )  STRONG BUT INDECISIVE JOBS REPORT, STUNNING TORY VICTORY AND POUND SURGES May 8, 2015 April Non-farm Private Payrolls came at 213K vs. 215K consensus, whisper numbers were all over the place from 150K to 300K.  Analyzing this report  beneath the surface, proves that our economic analysis over the last three months was correct in that the weakness in the economic data was related to transient factors. The main point for investors is that the report

Read More »

EXIT OR REDUCE SALESFORCE $CRM $MSFT $IBM $SAP $ORCL

This post was just published on ZYX Buy Change Alert. MSFT has denied that it is pursuing a bid for CRM.  In our analysis, eventually this stock will be bought by one of the bigger companies such as MSFT, IBM, SAP, and ORCL.  However,  over the coming months there is likely to be an opportunity to buy the stock at a lower price.   Please stay tuned to the Real Time Feed of ZYX Buy Change Alert. What To Do Now? Those in the stock have two options to consider.  Either get out right here, or continue to hold a very small quantity such

Read More »

TAKING PARTIAL PROFITS ON ALIBABA AHEAD OF EARNINGS $BABA

This post was just published on ZYX Buy Change Alert. BABA position is long from $68.   80% of the full core position size is being held. Profits have been taken as high as $110.63.    The stock is trading at $80.06 as of this writing. There is significant risk in the earnings to be reported tomorrow both on the upside and the downside.  It is prudent to take profits on a 30% tranche in the zone of $80 to $82.63 before the release of earnings. After this profit taking 50% of the full core position size will remain. You are receiving less than 2% of

Read More »

TAKE PARTIAL PROFITS ON PTC THERAPEUTICS $PTCT

This post was just published on ZYX Short Change Alert. Consider taking partial profits on a 25% tranche of PTCT in the zone of $50.61 to $53.31.  As of this writing it is trading at $53.13 in the premarket.  Consider continuing to hold the remaining 20%.  You are receiving less than 2% of the content from our paid services …TO RECEIVE REMAINING 98%, TAKE A FREE TRIAL TO PAID SERVICES. Please click here to take advantage of a FREE  30 day trial. Check out our enviable performance in both bull and bear markets.

Read More »

UPDATE ON BLUEPRINT MEDICINE $BPMC $IBB $XBI $BBH $BIS

This post was just published on ZYX Buy Change Alert. In view of overall market conditions, especially the negative money flow in biotechs, consider accumulating a maximum of 40% of BPMC.  Previous call was to accumulate up to 60%.  Please adjust the quantity based on your own risk tolerance. You are receiving less than 2% of the content from our paid services …TO RECEIVE REMAINING 98%, TAKE A FREE TRIAL TO PAID SERVICES. Please click here to take advantage of a FREE  30 day trial. Check out our enviable performance in both bull and bear markets.

Read More »

A NEW IDEA ON SALESFORCE $CRM $MSFT $GOOG $ORCL $SAP $IBM $AMZN

This post was just published on ZYX Buy Change Alert. There are rumors that MSFT is considering a bid for CRM.  There is risk in this trade because the stock is already up about $3.  This trade is suitable for aggressive investors only as the risk of loss is high. Consider accumulating up to 30% of the full core position size  in the zone of $71 to $75.20.  The stop zone is $69.23 to $69.43.  Target zone is $88 to $93. You are receiving less than 2% of the content from our paid services …TO RECEIVE REMAINING 98%, TAKE A FREE

Read More »

WEEKLY MARKET DIGEST: FED PREDICTS GROWTH, MARKET THROWS A TANTRUM, SMART MONEY SELLS GOLD $GLD $SLV $USO $DIA $SPY $QQQ $TBF $TBT

  (The Weekly Digest reproduces the morning capsules made available every morning before the market open in the Real Time Feeds to the paying subscribers. )  MARKET THROWS A TANTRUM, SMART MONEY SELLS GOLD May 1, 2015 Yesterday the stock market threw a tantrum.  The tantrum was not unexpected.  The economic data showed that economies in both the U. S. and Europe are getting better. The markets are addicted to bad economies and monetary easing by the central banks. At some point, there has to be the start of a transition for the markets to move based on economic realities

Read More »

A NEW IDEA ON BLUEPRINT MEDICINE $BPMC $IBB $XBI $BBH $BIS

This post was just published on ZYX Buy Change Alert. BPMC is a biotech firm focused on developing cancer treatment therapies.   This is a new IPO.  It is a high risk high reward situation suitable only for aggressive investors as the risk of loss is high. Here is the plan: Consider buying a 5% tranche in the zone of $22.00 to $23.50. It is trading at $23 as of this writing.  Consider buying a 10% tranche in the zone of $21.00 to $21.67; another 10% tranche in the zone of $20 to $20.37.  10% in the zone of  $19.00 to $19.31 and

Read More »

AI is power hungry. Investors will make a fortune from nuclear power for AI.
Get the list of 12 nuclear power stocks to grab your share of the profits.

AI is power hungry. Investors will make a fortune from nuclear power for AI.

Get the list of 12 nuclear power stocks to grab your share of the profits.

Big Tech is investing billions

Making A Fortune
In Nuclear Energy

Golden Age of Nuclear Energy

Skip to content